Quarterly injection stops bone loss

An intravenous formulation of Roche's bisphosphonate Bonviva (ibandronic acid 3mg/mL) has been licensed for the treatment of postmenopausal osteoporosis.

Administered every three months by intravenous injection over 15-30 seconds, Bonviva IV provides long term protection against bone loss and reduces the risk of vertebral fractures. The intravenous formulation is particularly suitable for those women who find it difficult to follow the strict dosage regimen required for the oral formulation.

A two-year clinical study comparing the efficacy, safety and tolerability of the intravenous formulation with the oral formulation found that the intravenous formulation produced a greater increase in lumbar spine and hip bone mineral density than the oral formulation, was equally well tolerated and had a similar incidence of adverse reactions.

Bonviva IV is presented as a prefilled syringe costing £80.00.

Further information: Roche Products Ltd, Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire AL7 1TW. Tel: (01707) 366000.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases